Sort
82,697 grants matching “vaccine development”
Preclinical Evaluation of Novel Adenovirus Vectors
$1,222,577Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2008 · AI
Molecular approaches to understand vector-host and vector-pathogen interactions
$1,222,537Jesus Valenzuela · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Wirelessly controlled BSL3 vivarium system for automated microdosing in studies of infectious diseases
$1,222,524Tuan Q Hoang · Fluid Synchrony, Llc · R44 · FY2022 · OD
NATURAL HISTORY OF HPV--INFECTION TO NEOPLASIA
$1,222,379University Of California San Francisco · R01 · FY2003 · CA
Analysis of Host-Pathogen Interactions
$1,222,253Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Structure-Guided Design of Broadly Neutralizing Lassa Virus BiSpecific Antibodies
$1,222,182Luis Manuel Branco · Zalgen Labs, Llc · R01 · FY2020 · AI
Therapeutic Fully Human Monoclonal Antibodies against Vaccina Virus and Smallpox
$1,221,981Shane P Crotty · La Jolla Institute For Immunology · U01 · FY2010 · AI
Immunologic Correlates of Immunization for Cancer
$1,221,861University Of Washington · U54 · FY2002 · CA
Comprehensive Minority and Health Disparities Research Center - Phase III
$1,221,844Mona N. Fouad · University Of Alabama At Birmingham · P60 · FY2014 · MD
The connection of innate and adaptive anti-cancer immunity
$1,221,774John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Comprehensive Minority and Health Disparities Research Center - Phase III
$1,221,760Mona N. Fouad · University Of Alabama At Birmingham · P60 · FY2015 · MD
Cervical, Anal, and Oral HPV Persistence and Risk Factors Among Adolescent Girls
$1,221,286Angela Diaz · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · AI
Structure based design of trimer interface epitope focused universal influenza vaccines
$1,221,071James E Crowe · Vanderbilt University Medical Center · U01 · FY2022 · AI
NOVEL HIV VACCINES
$1,220,773University Of Md Biotechnology Institute · P01 · FY2002 · AI
Probiotics to Enhance Influenza Vaccine Immunogenicity
$1,220,717Patricia L Hibberd · Massachusetts General Hospital · U01 · FY2011 · AT
Task A12: SMALL ANIMAL MODELS FOR MYCOBACTERIA VACCINE TESTING
$1,220,654Linda Monum · Colorado State University · N01 · FY2014 · AI
An in vitro diagnostic assay for the early and accurate detection of platelet-activating antibodies associated with Heparin-induced Thrombocytopenia
$1,220,267Curtis Jones · Retham Technologies, Inc. · R44 · FY2023 · HL
Rapid response for pandemics: single cell sequencing and deep learning to predict antibody sequences against an emerging antigen
$1,219,945Animesh Ray · Keck Graduate Inst Of Applied Life Scis · R01 · FY2023 · AI
B Cell Epitope Mapping of Zika
$1,219,812Daved Fremont · Washington University · N01 · FY2017 · AI
Task A12: SMALL ANIMAL MODELS FOR MYCOBACTERIA VACCINE TESTING
$1,219,723Norman Kneteman · Colorado State University · N01 · FY2013 · AI
Upgrading infectious disease research facilities at University of Louisville RBL
$1,219,669Kenneth E Palmer · University Of Louisville · G20 · FY2022 · AI
Development of strategies to achieve immunoprotection against Cryptosporidiosis
$1,219,632Saul R Tzipori · University Of Maryland Baltimore · U19 · FY2015 · AI
REGULATION OF ANTI-TUMOR IMMUNITY
$1,219,441Eckhard R Podack · University Of Miami School Of Medicine · P01 · FY2010 · CA
Identification of the Initial Targets of Transmission
$1,219,391Thomas Hope · Northwestern University At Chicago · R01 · FY2013 · AI
Studies of Receptor Interactions and Effects of Alarmins
$1,219,341Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA